4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-068922
Chief Executive Officer bought 1,740 shares at $0.88 ($1,531)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sullivan Eddie Joe Chief Executive Officer | 2023-12-07 | Purchase | +1,740 | $0.88 | $1,531 | 5,232,304 | D |
| Open-market purchases · 1,740 sh · avg $0.88 · $1,531 | |||||||
Loading xslF345X05/ownership.xml…